Pharmacogenomics is the study of genes and how they impact drug response in certain individuals. This information allows physicians to customize treatment plans for their patients by taking into account a patient’s genetic unique background. How have these emerging technologies changed the structure of drug development? In today's episode, Darshan Kulkarni discusses the implications of pharmacogenomics for the drug approval process, and how it may impact FDA regulatory law.